We used the chi-square test to analyze clinicopathological data from pancreatic cancer patients and found that TNFR2 expression was positively correlated with aggressive clinicopathologic characteristics, including tumor size, lymph node metastasis, and differentiation. Here, TNFRSF1B is linked to pancreatic neoplasm.